Government Shutdown End Boosts Stocks, Led by Tech

Government shutdown end prospects boosted stocks after the Senate advanced a funding package, sparking a tech-led rally and raising volatility risk.

November 10, 2025·2 min read
View all news articles
Flat-vector microchip cluster buoyed by government funding, symbolizing government shutdown end and tech-led market rally.

KEY TAKEAWAYS

  • Senate advanced a bipartisan funding package, raising prospects for a government shutdown end.
  • Technology-led rally pushed the Nasdaq up 2.3% and the S&P 500 up 1.5%.
  • House approval and presidential signature plus delayed economic data could prolong volatility.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

U.S. stocks rallied on Nov. 10, 2025, after the Senate advanced a bipartisan funding package that raised prospects for a government shutdown end, lifting tech shares even as traders warned that delayed economic data and pending approvals could increase volatility.

Senate Advances Funding Package to End Shutdown

On Nov. 9, the Senate reached the 60-vote threshold to advance a bipartisan funding package, with seven Democrats and Sen. Angus King (I-ME) joining Republicans. The measure includes a three-bill, full-year spending package covering the Department of Agriculture, Food and Drug Administration, legislative branch, Department of Defense construction, and Department of Veterans Affairs. It also contains a short-term continuing resolution to fund other government entities through Jan. 30, 2026, and extends key healthcare waivers and flexibilities until that date.

The package still requires approval by the House and the President’s signature before the government fully reopens. Senate leaders secured a commitment for a future floor vote on extending enhanced premium tax credits set to expire at year-end.

Tech Shares Lead Market Rally Amid Volatility Risks

Technology stocks led the market rebound, with the Nasdaq Composite rising 2.3% and the S&P 500 up 1.5% that day. The gains reflected easing immediate fiscal concerns as lawmakers advanced the funding package.

Market participants expect a surge of delayed U.S. economic data that could increase volatility and complicate the Federal Reserve’s policy decisions. Analysts cautioned that the incoming reports might reshape expectations about growth and inflation in unpredictable ways.

Some optimism also stemmed from expectations of a Republican sweep, which some viewed as supportive for equities. Despite the Senate’s progress, analysts warned that the backlog of data and ongoing fiscal and monetary uncertainty could keep near-term volatility elevated as investors reassess the outlook.

For now, the Senate’s action eased one immediate political risk and boosted risk assets, but the rally’s durability depends on the House’s response, the President’s approval, and how markets interpret the delayed economic data.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

U.S.-Switzerland Trade Deal Lowers Tariffs

U.S.-Switzerland trade deal eases pressure on Swiss watch and pharmaceutical exporters and reduces a near-term sales and pricing headwind for traders.

Ron Baron Tesla Sees $2,500 Target, Holds Stakes

Ron Baron Tesla reaffirmed a lifetime hold and backed Musk's pay package, spotlighting governance and focusing investors on his $2,500 Tesla price target.

StubHub Q3 Earnings: Stock Falls After Guidance Withheld

StubHub Q3 earnings showed revenue growth but a large IPO-related net loss and no Q4 guidance, prompting a steep share selloff and pressured positioning.

Lundbeck Bid for Avadel Tops Alkermes Deal

Lundbeck Bid for Avadel raises takeover stakes by topping Alkermes' signed agreement and could force matching or renegotiation that reshapes deal certainty

Merck To Acquire Cidara Therapeutics

Merck to acquire Cidara strengthens its antiviral and respiratory pipeline ahead of Keytruda patent expiry and shifts near-term trader positioning.

Walmart CEO Transition Names John Furner

Walmart CEO transition names John Furner; the board appointment and handover aim to preserve operational continuity and limit governance uncertainty.